ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
61 388,58
0,82%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. CV Therapeutics (MM) (CVTX)

  7. CV Therapeutics (MM) (CVTX) Actualités

CVTX

CV Therapeutics (CVTX)

CV Therapeutics (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CVTX
DateHeureSourceTitreSymboleSociété
17/04/200923h01Edgar (US Regulatory)Termination of Registration of a Class of Security under Section 12(g) (15-12G)NASDAQ:CVTXCV Therapeutics (MM)
17/04/200922h32Edgar (US Regulatory)(25-NSE)NASDAQ:CVTXCV Therapeutics (MM)
17/04/200922h15Business WireGilead Sciences Completes Acquisition of CV TherapeuticsNASDAQ:CVTXCV Therapeutics (MM)
17/04/200919h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
15/04/200921h54Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
14/04/200912h06Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
09/04/200922h53Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CVTXCV Therapeutics (MM)
09/04/200921h11Edgar (US Regulatory)Schedule 13GNASDAQ:CVTXCV Therapeutics (MM)
08/04/200916h49MarketwiredAnalystChoice.com Free Investment Opinion on PPDI, MEDX, CVTX and OSIPNASDAQ:CVTXCV Therapeutics (MM)
06/04/200922h12Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:CVTXCV Therapeutics (MM)
18/03/200922h05MarketwiredCV Therapeutics' Board of Directors Recommends Stockholders Accept Gilead Sciences' $20.00 per Share Cash Tender OfferNASDAQ:CVTXCV Therapeutics (MM)
18/03/200921h44Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:CVTXCV Therapeutics (MM)
18/03/200921h42Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:CVTXCV Therapeutics (MM)
18/03/200918h53Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CVTXCV Therapeutics (MM)
18/03/200918h52Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:CVTXCV Therapeutics (MM)
17/03/200914h07MarketwiredRun of 100% Profitable Stock Alerts Marches on for BullTradeNASDAQ:CVTXCV Therapeutics (MM)
16/03/200922h13Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)NASDAQ:CVTXCV Therapeutics (MM)
16/03/200921h57Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Reserves, Cheap Stocks Could Trigger More M&ANASDAQ:CVTXCV Therapeutics Inc.
16/03/200921h01MarketwiredCV Therapeutics Announces Presentations at the American College of Cardiology 58th Annual Scientific SessionNASDAQ:CVTXCV Therapeutics (MM)
16/03/200920h01Dow Jones NewsUPDATE: US Drug Sector Rises After Bernanke CommentsNASDAQ:CVTXCV Therapeutics Inc.
16/03/200919h49Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Warchests, Cheap Stocks Could Trigger More M&ANASDAQ:CVTXCV Therapeutics Inc.
16/03/200916h10Dow Jones NewsDrug Sector Rises As Fed Chief Bernanke's Upbeat On RecessionNASDAQ:CVTXCV Therapeutics Inc.
16/03/200910h12Dow Jones NewsUPDATE:Astellas Pharma Abandons Offer To Buy CV TherapeuticsNASDAQ:CVTXCV Therapeutics Inc.
16/03/200908h08Dow Jones NewsAstellas Pharma: Withdrawing Offer To Buy CV TherapeuticsNASDAQ:CVTXCV Therapeutics Inc.
16/03/200907h42Business WireAstellas to Terminate Offer for CV TherapeuticsNASDAQ:CVTXCV Therapeutics (MM)
13/03/200913h45Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsNASDAQ:CVTXCV Therapeutics Inc.
12/03/200922h03Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:CVTXCV Therapeutics (MM)
12/03/200919h15PR Newswire (US)CV Therapeutics' Board of Directors Rejects Astellas' Tender OfferNASDAQ:CVTXCV Therapeutics (MM)
12/03/200915h06Dow Jones NewsUPDATE: Gilead To Buy CV Therapeutics For $1.4 BillionNASDAQ:CVTXCV Therapeutics Inc.
12/03/200914h22Dow Jones NewsGilead To Buy CV Therapeutics For $1.4 Billion In White-Knight BidNASDAQ:CVTXCV Therapeutics Inc.
 Showing the most relevant articles for your search:NASDAQ:CVTX

Dernières Valeurs Consultées

TG
ALTC
WisdomTree Commodity Sec...
XE
WEBC
Amundi ETF ICAV
COIN
INDEXETH
Index
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés